HSK41959

· Haisco Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HSK41959, covering 2025-05-13 to 2025-05-13. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study of HSK41959 in Solid Tumors With MTAP Deletion [Phase 1]